AspenBio Pharma, Inc.·4

May 24, 9:05 AM ET

Hurd Donald R 4

4 · AspenBio Pharma, Inc. · Filed May 24, 2012

Insider Transaction Report

Form 4
Period: 2012-05-23
Hurd Donald R
SVP, Chief Commerical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-05-23+120,000120,000 total
    Exercise: $0.57Exp: 2022-05-23Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option to purchase 120,000 shares of common stock shall become exercisable as to 50% of the shares on November 23, 2012, as to 8.33% of the shares on each of December 23, 2012, January 23, 2013, February 23, 2013, and March 23, 2013, and as to 8.34% of the shares on each of April 23, 2013 and May 23, 2013.

Documents

1 file
  • 4
    appy_hurd4.xmlPrimary

    OWNERSHIP DOCUMENT